Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SPROthis companySpero Therapeutics, Inc.	$1.03	15.53×	2.21×	2.19×	10.55×	-2700.7%	100.0%	-0.0%	14.4%	14.5%	-0.0%	-9.7%	0.05×	-4.23×	0×	7.59×	0.0%	6	-5.89	4	A-
ABOSAcumen Pharmaceuticals, Inc.	$0.22	-1.06×	1.81×	0×	-0.9×	56.7%	0.0%	0.0%	0.0%	-172.3%	-121.7%	-90.5%	0.44×	0.19×	-29.32×	4.07×	0.0%	2	-11.67	2	C
ACTUActuate Therapeutics Inc	$0.34	-5.77×	16.24×	0×	-5.22×	57.8%	0.0%	0.0%	0.0%	-280.5%	-270.1%	-14.9%	0.05×	0.57×	-1,110.88×	2.39×	0.0%	2	-56.06	2	C
CGTXCognition Therapeutics, Inc.	$0.69	-4.22×	2.87×	0×	-2.67×	-14.9%	0.0%	0.0%	0.0%	-68.5%	-136.9%	-25.0%	0.02×	1.56×	-3,676.85×	3.45×	0.0%	1	-0.97	2	C+
CRBPCorbus Pharmaceuticals Holdings, Inc.	$3.13	-1.38×	0.73×	0×	-1.04×	-49.7%	0.0%	0.0%	0.0%	-53.2%	-57.2%	-59.5%	0.01×	0.34×	0×	8.07×	0.0%	1	-6.62	2	B-
HURATuHURA Biosciences, Inc.	$1.73	-1.2×	1.73×	0×	-1.14×	-100.8%	0.0%	0.0%	0.0%	-143.6%	-145.7%	-76.4%	0.03×	0.1×	-50.85×	0.78×	0.0%	1	-5.35	2	C
Peer median	—	-1.38×	1.81×	0×	-1.14×	-14.9%	0.0%	0.0%	0.0%	-143.6%	-136.9%	-59.5%	0.03×	0.34×	-50.85×	3.45×	0.0%	1	-6.62	2	—